nuevos biomarcadores para la detecciÓn de la insuficiencia renal aguda

Clicks: 175
ID: 159173
2013
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #13 of 36 articles by views in animal models and experimental medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Acute renal failure (ARF) is one of the main renal disorders, which is characterized by deterioration (in hours or days) of the glomerular filtration rate. Serum creatinine is the marker typically used in clinical practice for the diagnosis and monitoring of the IRA. However, it has the disadvantage of being a late marker and influenced by multiple variables. In order to overcome this limitation new biomarkers of AKI were obtained, such as interleukin 18 (Interleukin 18), gelatinase-associated lipocalin neutrophil (neutrophil gelatinase-associated lipocalin), kidney injury molecule (kidney injury molecule) and cystatin C (cystatin-C), which have higher sensitivity, specificity and ability to determine the location of the damage and the IRA evolution respect to serum creatinine.
Reference Key
ae2013electronicnuevos Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Medina Ayala AE
Journal animal models and experimental medicine
Year 2013
DOI
DOI not found
URL
http://biomed.uninet.edu/2013/n2/medina.html
Keywords
acute renal failure biomarkersmedicinemedicine (general)

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.